EDIT vs PGR · rev $32.3M vs P/E 10, rev $87.67B
Editas Medicine Inc (EDIT) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
EDIT currently screens at market cap $375.2M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the EDIT and PGR stock pages for the full models.
Not investment advice.